依西酞普兰
安慰剂
医学
置信区间
随机化
麻醉
经颅直流电刺激
5-羟色胺再摄取抑制剂
萧条(经济学)
内科学
随机对照试验
刺激
抗抑郁药
替代医学
经济
病理
宏观经济学
海马体
作者
André R. Brunoni,Adriano H. Moffa,Bernardo Sampaio-Júnior,Lucas Borrione,Marina Moreno,Raquel Albano Fernandes,Beatriz Veronezi,Barbara Schwair Nogueira,Luana V M Aparicio,Laís B. Razza,Renan Chamorro,Luara C. Tort,Renério Fráguas,Paulo A. Lotufo,Wagner F. Gattaz,Felipe Fregni,Isabela M. Benseñor
标识
DOI:10.1056/nejmoa1612999
摘要
In a single-center trial, tDCS for the treatment of depression did not show noninferiority to escitalopram over a 10-week period and was associated with more adverse events. (Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo and others; ELECT-TDCS ClinicalTrials.gov number, NCT01894815 .).
科研通智能强力驱动
Strongly Powered by AbleSci AI